First-line chemotherapy of advanced or metastatic breast cancer (MBC) with docetaxel and doxorubicin in Indonesia: results from A phase II trial

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase II Trial of Weekly vs. Every 2 Weeks vs. Every 3 Weeks Nanoparticle Albumin-Bound Paclitaxel With Bevacizumab as First-Line Chemotherapy for Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2013.02.008 ◽

2013 ◽

Vol 13 (4) ◽

pp. 239-246.e1 ◽

Cited By ~ 19

Author(s):

Andrew D. Seidman ◽

Alison K. Conlin ◽

Ariadne Bach ◽

Mary Ellen Moynahan ◽

Diana Lake ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

Phase II Trial of Nab-Paclitaxel Compared With Docetaxel as First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Final Analysis of Overall Survival

Clinical Breast Cancer ◽

10.1016/j.clbc.2012.05.001 ◽

2012 ◽

Vol 12 (5) ◽

pp. 313-321 ◽

Cited By ~ 71

Author(s):

William J. Gradishar ◽

Dimitry Krasnojon ◽

Sergey Cheporov ◽

Anatoly N. Makhson ◽

Georgiy M. Manikhas ◽

...

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Final Analysis ◽

First Line ◽

Phase II Trial of Weekly Docetaxel/Gemcitabine as First-Line Chemotherapy in Patients with Locally Recurrent or Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.3816/cbc.2006.n.003 ◽

2006 ◽

Vol 6 (6) ◽

pp. 505-510 ◽

Cited By ~ 15

Author(s):

Joyce A. O'Shaughnessy ◽

Robert Pluenneke ◽

Jack Sternberg ◽

Pankaj Khandelwal ◽

Des Ilegbodu ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Weekly Docetaxel ◽

Locally Recurrent ◽

North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer

Annals of Oncology ◽

10.1093/annonc/mdp512 ◽

2010 ◽

Vol 21 (2) ◽

pp. 269-274 ◽

Cited By ~ 23

Author(s):

E.A. Perez ◽

D.W. Hillman ◽

T. Dentchev ◽

N.A. Le-Lindqwister ◽

L.H. Geeraerts ◽

...

Keyword(s):

Breast Cancer ◽

Treatment Group ◽

Cancer Treatment ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

North Central ◽

Anti-hormonal maintenance treatment with or without the CDK4/6 inhibitor ribociclib after first line chemotherapy in hormone receptor positive/HER2 negative metastatic breast cancer: A phase II trial (AMICA) GBG 97

Annals of Oncology ◽

10.1093/annonc/mdy272.352 ◽

2018 ◽

Vol 29 ◽

pp. viii119

Author(s):

T. Decker ◽

C. Denkert ◽

K. Lübbe ◽

V. Müller ◽

C. Mundhenke ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Hormone Receptor ◽

Maintenance Treatment ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Hormone Receptor Positive ◽

Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer

British Journal of Cancer ◽

10.1038/sj.bjc.6601518 ◽

2004 ◽

Vol 90 (1) ◽

pp. 31-35 ◽

Cited By ~ 22

Author(s):

F Cappuzzo ◽

F Mazzoni ◽

A Gennari ◽

S Donati ◽

B Salvadori ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

A Phase II Trial of Docetaxel and Carboplatin as First-Line Chemotherapy for Metastatic Breast Cancer: NCCTG Study N9932

Oncology ◽

10.1159/000087813 ◽

2005 ◽

Vol 69 (2) ◽

pp. 117-121 ◽

Cited By ~ 10

Author(s):

Edith A. Perez ◽

Vera J. Suman ◽

Tom R. Fitch ◽

James A. Mailliard ◽

James N. Ingle ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Weekly paclitaxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicentre phase II trial

European Journal of Cancer ◽

10.1016/j.ejca.2003.08.013 ◽

2004 ◽

Vol 40 (3) ◽

pp. 352-357 ◽

Cited By ~ 46

Author(s):

A.J ten Tije ◽

C.H Smorenburg ◽

C Seynaeve ◽

A Sparreboom ◽

K.L.C Schothorst ◽

...

Keyword(s):

Breast Cancer ◽

Elderly Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Weekly Paclitaxel ◽

First Line ◽

Multicentre Phase ◽

All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial

British Journal of Cancer ◽

10.1038/sj.bjc.6605156 ◽

2009 ◽

Vol 101 (2) ◽

pp. 232-237 ◽

Cited By ~ 29

Author(s):

N Tubiana-Mathieu ◽

P Bougnoux ◽

D Becquart ◽

A Chan ◽

P-F Conte ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Oral Vinorelbine ◽

Phase II Trial of Weekly Vinorelbine and Trastuzumab as First‐Line Therapy in Patients with HER2 + Metastatic Breast Cancer

The Oncologist ◽

10.1634/theoncologist.7-5-410 ◽

2002 ◽

Vol 7 (5) ◽

pp. 410-417 ◽

Cited By ~ 107

Author(s):

Mohammad Jahanzeb ◽

Joanne E. Mortimer ◽

Furhan Yunus ◽

David H. Irwin ◽

James Speyer ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy